Immunology of skin diseases: chairman's introductionBOS, J. D.Acta dermato-venereologica. Supplementum. 1989, Vol 69, Num 151, issn 0365-8341, 55 [1 p.], supplConference Paper

The skin immune system : lupus erythematosus as a paradigmBOS, J. D.Archives of dermatological research (Print). 1994, Vol 287, Num 1, pp 23-27, issn 0340-3696Article

The pathomechanisms of psoriasis. The skin immune system and cyclosporinBOS, J. D.British journal of dermatology (1951). 1988, Vol 118, Num 2, pp 141-155, issn 0007-0963Article

Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans' cells and interdigitating cellsBOS, J. D; KRIEG, S. R.Acta dermato-venereologica. 1985, Vol 65, Num 5, pp 390-397, issn 0001-5555Article

Long-term efficacy of a single course of infliximab in hidradenitis suppurativaMEKKES, J. R; BOS, J. D.British journal of dermatology (1951). 2008, Vol 158, Num 2, pp 370-374, issn 0007-0963, 5 p.Article

Demodicidosis or rosacea : what did we treat ?HOEKZEMA, R; HULSEBOSCH, H. J; BOS, J. D et al.British journal of dermatology (1951). 1995, Vol 133, Num 2, pp 294-299, issn 0007-0963Article

Updates in dermatology, Reykjavik, 7th April 1989BOS, J. D; HAVU, V. K.Acta dermato-venereologica. Supplementum. 1989, Vol 69, Num 151, issn 0365-8341, 3 p., non paginées, 1-110 [113 p.], supplConference Proceedings

Repigmentation in vitiligo vulgaris by autologous minigrafting : results in nineteen patientsBOERSMA, B. R; WESTERHOF, W; BOS, J. D et al.Journal of the American Academy of Dermatology. 1995, Vol 33, Num 6, pp 990-995, issn 0190-9622Article

The skin immune system : progress in cutaneous biologyBOS, J. D; KAPSENBERG, M. L.Immunology today (Amsterdam. Regular ed.). 1993, Vol 14, Num 2, pp 75-78, issn 0167-5699Article

The 500 Dalton rule for the skin penetration of chemical compounds and drugsBOS, J. D; MEINARDI, M. M. H. M.Experimental dermatology. 2000, Vol 9, Num 3, pp 165-169, issn 0906-6705Article

Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapyNJOO, M. D; BOS, J. D; WESTERHOF, W et al.Journal of the American Academy of Dermatology. 2000, Vol 42, Num 2, pp 245-253, issn 0190-9622, 1Article

Preservatives in the European standard series for epicutaneous testingDE GROOT, A. C; BOS, J. D.British journal of dermatology (1951). 1987, Vol 116, Num 3, pp 289-292, issn 0007-0963Article

Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methodsKEZIC, S; KAMMEYER, A; CALKOEN, F et al.British journal of dermatology (1951). 2009, Vol 161, Num 5, pp 1098-1104, issn 0007-0963, 7 p.Article

A multicentre, randomized, double-blind, controlled study of long-term treatment with 01% tacrolimus ointment in adults with moderate to severe atopic dermatitisREITAMO, S; ORTONNE, J. P; SAND, C et al.British journal of dermatology (1951). 2005, Vol 152, Num 6, pp 1282-1289, issn 0007-0963, 8 p.Article

Psoriasis : dysregulation of innate immunityBOS, J. D; DE RIE, M. A; TEUNISSEN, M. B. M et al.British journal of dermatology (1951). 2005, Vol 152, Num 6, pp 1098-1107, issn 0007-0963, 10 p.Article

Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-γ inducers -IL-12, IL-18 and IL-23PISKIN, G; TURSEN, U; SYLVA-STEENLAND, R. M. R et al.Experimental dermatology. 2004, Vol 13, Num 12, pp 764-772, issn 0906-6705, 9 p.Article

Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform methodDE RIE, M. A; ENOMOTO, D. N. H; DE VRIES, H. J. C et al.Dermatology (Basel). 2003, Vol 207, Num 3, pp 298-301, issn 1018-8665, 4 p.Article

Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levelsHEYDENDAEL, V. M. R; SPULS, P. I; TEN BERGE, I. J. M et al.British journal of dermatology (1951). 2002, Vol 147, Num 1, pp 122-129, issn 0007-0963Article

SDZ ASM 981 : an emerging safe and effective treatment for atopic dermatitisLUGER, T; VAN LEENT, E. J. M; KNULST, A. C et al.British journal of dermatology (1951). 2001, Vol 144, Num 4, pp 788-794, issn 0007-0963Article

Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute woundsLOOTS, M. A. M; LAMME, E. N; ZEEGELAAR, J et al.Journal of investigative dermatology. 1998, Vol 111, Num 5, pp 850-857, issn 0022-202XArticle

Cyclosporine immunotherapyDE RIE, M. A; BOS, J. D.Clinics in dermatology. 1997, Vol 15, Num 5, pp 811-821, issn 0738-081XArticle

Corticosteroids class-dependently inhibit in vitro Th1- and Th2-type cytokine productionSNIJDEWINT, F. G. M; KAPSENBERG, M. L; WAUBEN-PENRIS, P. J. J et al.Immunopharmacology (New York). 1995, Vol 29, Num 2, pp 93-101, issn 0162-3109Article

In situ behavior of human Langerhans cells in skin organ cultureRAMBUKKANA, A; BOS, J. D; IRIK, D et al.Laboratory investigation. 1995, Vol 73, Num 4, pp 521-531, issn 0023-6837Article

Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis : a possible mechanism of vascular damageVENNEKER, G. T; VAN DEN HOOGEN, F. H. J; BOERBOOMS, A. M. T et al.Laboratory investigation. 1994, Vol 70, Num 6, pp 830-835, issn 0023-6837Article

Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endotheliumVENNEKER, G. T; DAS, P. K; NAAFS, B et al.British journal of dermatology (1951). 1994, Vol 131, Num 2, pp 237-242, issn 0007-0963Article